Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMC Samsung Volvo
you are here:

Nippon India Pharma Fund - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
  • NAV
    : ₹ 251.1087 -0.39%
    (as on 22nd January, 2021)
Crisil Rank

Not Ranked

Rank not available for the fund
Risk-O-Meter
High
(Min ₹100 for SIP, ₹5000 for one time investment)

Fund has 97.71% investment in indian stocks of which 57.69% is in large cap stocks, 18.16% is in mid cap stocks, 11.84% in small cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    S&P BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • S&P BSE Healthcare TRI : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 22nd January, 2021)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 15-Jan-21 9735.50 -2.64% - -1.25% 98/120
1 Month 22-Dec-20 10220.60 2.21% - 6.67% 111/119
3 Month 22-Oct-20 11142.70 11.43% - 21.42% 103/114
6 Month 22-Jul-20 12900.50 29.01% - 30.02% 62/113
YTD 01-Jan-21 9850.20 -1.50% - 2.65% 111/121
1 Year 22-Jan-20 16021.30 60.21% 60.01% 20.69% 8/111
2 Year 22-Jan-19 16554.10 65.54% 28.62% 14.47% 11/101
3 Year 22-Jan-18 17236.60 72.37% 19.88% 5.66% 7/87
5 Year 22-Jan-16 18336.60 83.37% 12.88% 12.81% 39/86
10 Year 21-Jan-11 45030.40 350.30% 16.22% 10.32% 3/65
Since Inception 05-Jun-04 251108.70 2411.09% 21.37% 12.87% 14/128

SIP Returns (NAV as on 22nd January, 2021)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 22-Jan-20 12000 15880.42 32.34 % 64.41 %
2 Year 22-Jan-19 24000 36567.63 52.37 % 46.26 %
3 Year 22-Jan-18 36000 57254.77 59.04 % 32.48 %
5 Year 22-Jan-16 60000 102061.9 70.1 % 21.35 %
10 Year 21-Jan-11 120000 302466.81 152.06 % 17.58 %
 

Tax Treatment

Portfolio (Updated on 31st Dec,2020)

Portfolio Turnover Ratio : 58.00%  |   Category average turnover ratio is 107.25%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 97.71% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 97.71%
No of Stocks : 21 (Category Avg - 33.15) | Large Cap Investments : 57.69%| Mid Cap Investments : 18.16% | Small Cap Investments : 11.84% | Other : 10.02%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 4739.4 10.81% 0.95% 10.81% (Dec 2020) 9.56% (Oct 2020) 80.01 L 0.00
Aurobindo Pharma Ltd. Pharmaceuticals 4606.5 10.51% 0.05% 11.96% (May 2020) 5.83% (Jan 2020) 50.00 L 0.00
Cipla Ltd. Pharmaceuticals 4099.8 9.35% 0.37% 10.4% (May 2020) 7.86% (Apr 2020) 50.00 L 0.00
Divis Laboratories Ltd. Pharmaceuticals 4034 9.20% -0.35% 10.26% (Aug 2020) 7.74% (Jun 2020) 10.50 L -0.50 L
Lupin Ltd. Pharmaceuticals 3907.4 8.91% 0.32% 10.3% (Sep 2020) 4.76% (Feb 2020) 40.00 L 0.00
Dr. Reddys Laboratories Ltd. Pharmaceuticals 3903.8 8.91% 1.64% 11.04% (Mar 2020) 7.27% (Nov 2020) 7.50 L 1.25 L
Cadila Healthcare Ltd. Pharmaceuticals 2860 6.52% 0.02% 6.52% (Dec 2020) 2.71% (Feb 2020) 59.99 L 0.00
Fortis Healthcare Ltd. Hospital 2483.8 5.67% 0.43% 5.73% (Feb 2020) 4.1% (May 2020) 1.60 Cr 16.00 L
Gland Pharma Ltd. Pharmaceuticals 1905.8 4.35% -2.13% 6.48% (Nov 2020) 0% (Jan 2020) 8.15 L -4.58 L
Thyrocare Technologies Ltd. Healthcare service providers 1863.9 4.25% -1.31% 6.84% (Oct 2020) 4.2% (Jun 2020) 20.42 L -0.62 L
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
TREPS TREPS 2.44%
Margin Margin 0.33%
Net Receivables Net Receivables -0.48%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 31st December, 2020)

  • Standard Deviation

    High volatility
    18.93vs14.61
    Category Avg
  • Beta

    High volatility
    0.9vs0.61
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    0.9vs0.14
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.19vs0.04
    Category Avg
  • Jension's Alpha

    Better risk adjusted returns
    6.86vs-1.49
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
ICICI Prudential Technology Fund - Growth 3 1184.58 9.36 21.34 61.17 69.78 26.79
DSP Healthcare Fund - Regular Plan - Growth NA 1043.27 2.30 10.30 34.17 64.62 0.00
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth NA 2159.31 1.33 10.47 29.01 62.46 0.00
Mirae Asset Healthcare Fund - Growth NA 1209.93 0.53 7.14 28.19 61.99 0.00
Franklin India Technology Fund - Growth 1 471.85 9.96 22.10 44.97 61.08 25.45
SBI Healthcare Opportunities Fund - Regular Plan - Growth NA 1575.33 3.54 11.31 32.47 60.77 14.34
Aditya Birla Sun Life Digital India Fund - Regular Plan - Growth 4 861.20 10.39 21.61 54.68 59.56 25.60
UTI Healthcare - Growth NA 649.26 0.54 7.69 28.69 57.76 15.04
Tata Digital India Fund - Growth NA 812.53 11.52 21.00 54.09 57.41 26.20
Tata India Pharma & Heathcare Fund - Growth NA 419.33 1.64 10.68 31.43 56.28 17.94

More Funds from Nippon India Mutual Fund

Out of 161 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 5 is/are ranked 4 * , 8 is/are ranked 3 * , 9 is/are ranked 2 * , 11 is/are ranked 1 * , and 127 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Liquid Fund - Growth 3 23245.11 0.23 0.71 1.54 4.09 6.04
Nippon India Floating Rate Fund - Growth 3 15771.35 -0.13 1.19 2.88 10.43 8.44
CPSE ETF NA 12518.20 1.78 23.65 13.98 -5.74 -12.02
CPSE ETF NA 12518.20 1.73 23.51 14.01 -6.24 -12.47
Nippon India Small Cap Fund - Growth 3 10916.19 7.50 23.25 42.01 23.63 1.64
Nippon India Tax Saver Fund - Growth 1 10563.69 7.82 22.70 29.31 3.37 -6.28
Nippon India Large Cap Fund - Growth 1 10434.50 8.36 25.00 30.41 9.15 4.13
Nippon India Short Term Fund - Growth 2 8709.68 -0.01 1.17 2.79 8.69 7.94
Nippon India Multicap Fund - Growth 1 8505.80 7.71 23.09 31.29 2.06 -0.01
Nippon India Growth Fund - Growth 3 8187.72 8.79 25.57 38.50 22.11 6.53

Forum

+ See More